CAS 19573-01-4: BYAKANGELICIN
Formula:C17H18O7
InChI:InChI=1/C17H18O7/c1-17(2,20)11(18)8-23-16-14-10(6-7-22-14)13(21-3)9-4-5-12(19)24-15(9)16/h4-7,11,18,20H,8H2,1-3H3/t11-/m1/s1
- Synonyms:
- 9-{[(2R)-2,3-dihydroxy-3-methylbutyl]oxy}-4-methoxy-7H-furo[3,2-g]chromen-7-one
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BYAKANGELICIN REF: IN-DA00ACKSCAS: 19573-01-4 | 99% | To inquire | Tue 04 Mar 25 |
 | (Rac)-Byakangelicin REF: TM-T3801CAS: 19573-01-4 | 98.99% - 99.94% | 48.00 €~520.00 € | Mon 03 Mar 25 |
 | Byakangelicin REF: 5G-89875CAS: 19573-01-4 | ≥ 95.0 % (HPLC) | 388.00 €~26,347.00 € | Tue 11 Mar 25 |
 | Byakangelicin-d3 REF: 3D-UAA57301CAS: 19573-01-4 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00ACKS
| 10mg | 157.00 € | ||
| 25mg | 294.00 € | ||
| 50mg | 471.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 4 Mar 2025
(Rac)-Byakangelicin
CAS:19573-01-4
(Rac)-Byakangelicin (7H-Furo[3,2-g][1]benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-) is an antineoplastic agent.
Formula:
C17H18O7
Purity:
98.99% - 99.94%
Color and Shape:
Solid
Molecular weight:
334.32
Ref: TM-T3801
| 1mg | 48.00 € | ||
| 5mg | 92.00 € | ||
| 10mg | 149.00 € | ||
| 25mg | 233.00 € | ||
| 50mg | 349.00 € | ||
| 100mg | 520.00 € | ||
| 1mL*10mM (DMSO) | 97.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
Byakangelicin
CAS:19573-01-4
Lactone
Formula:
C17H18O7
Purity:
≥ 95.0 % (HPLC)
Color and Shape:
Powder
Molecular weight:
334.33
Ref: 5G-89875
| 10mg | 388.00 € | ||
| 50mg | 1,581.00 € | ||
| 250mg | 7,465.00 € | ||
| 500mg | 14,052.00 € | ||
| 1000mg | 26,347.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Byakangelicin-d3
CAS:19573-01-4
Byakangelicin-d3 is a sesquiterpene oligoglycoside that is isolated from the bark of the tree Byakangelica. …
Formula:
C17H18O7
Purity:
Min. 95%
Molecular weight:
334.3 g/mol
Ref: 3D-UAA57301
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
